EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study

Sara Câmara iD, Daniela Pereira, Saudade André, Beatriz Mira, Fátima Vaz, Rodrigo Oom, José Carlos Marques, João Leal de Faria, Catarina Rodrigues Dos Santos

International Journal of Breast Cancer · 2018 · 2018 · 1-7

DOI: 10.1155/2018/1426369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Breast Cancer, 2018. Verfasst von Sara Câmara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Hospital Dr. Nélio Mendonça, Avenida Luís de Camões, No. 57, 9004-514 Funchal, Portugal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sentinel lymph node biopsy in prophylactic mastectomy is controversial. It avoids lymphadenectomy in occult carcinoma but is associated with increased morbidity. Women with BRCA mutations have a higher incidence of occult carcinoma and our objective was to assess the clinical utility of sentinel lymph node biopsy when these women undergo prophylactic mastectomy. Materials and Methods. Seven-year retrospective consecutive case-series study of women, with a BRCA deleterious mutation, admitted to prophylactic mastectomy, at our center. Breast MRI < 6 months before surgery was routine, unless contraindicated.

Results

Fifty-seven patients (43% BRCA1; 57% BRCA2) underwent 80 prophylactic mastectomies. 72% of patients had had breast cancer treated before prophylactic mastectomy or synchronously to it. The occult carcinoma incidence was 5%, and half of the cases were invasive. SLNB was performed in 19% of the prophylactic mastectomies; none of these had tumor invasion. Women with invasive carcinoma who had not undergone sentinel lymph node biopsy were followed closely with axillary ultrasound. The median follow-up was 37 months, with no local recurrence; 1 patient died of primary tumor systemic relapse.

Conclusions

Our data do not support this procedure for routine (in agreement with previous literature), in this high risk for occult carcinoma population.

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Hospital Dr. Nélio Mendonça, Avenida Luís de Camões, No. 57, 9004-514 Funchal, Portugal.
  • Department of Pathology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal.
  • Department of Breast Cancer Risk Evaluation Clinic and Department of Medical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal.
  • Department of Surgical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal.
  • Radiology Department, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal.

ORCID-Profile: Sara Câmara

Zitieren

APA

Câmara, S., Pereira, D., André, S., Mira, B., Vaz, F., Oom, R., Marques, J. C., Leal de Faria, J., & Rodrigues Dos Santos, C. (2018). The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study. International Journal of Breast Cancer, 2018, 1-7. https://doi.org/10.1155/2018/1426369

Vancouver

Câmara S, Pereira D, André S, Mira B, Vaz F, Oom R, et al. The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study. International Journal of Breast Cancer. 2018;2018:1-7. doi:10.1155/2018/1426369

BibTeX
@article{Cmara2018,
  author = {Câmara, Sara and Pereira, Daniela and André, Saudade and Mira, Beatriz and Vaz, Fátima and Oom, Rodrigo and Marques, José Carlos and Leal de Faria, João and Rodrigues Dos Santos, Catarina},
  title = {The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study},
  journal = {International Journal of Breast Cancer},
  year = {2018},
  volume = {2018},
  pages = {1--7},
  doi = {10.1155/2018/1426369}
}
Kostenlos starten →